Discover How Certara's Proven AI Solutions Can Accelerate Your Drug Development Timeline
Welcome to Certara's October newsletter! As we “fall” into the final stretch of 2023, we're excited to share updates from our team. From advancements in AI technology to regulatory and medical writing solutions, we've got you covered. In this issue, discover how our proven AI solutions are accelerating drug development, learn about the latest trends in big data analytics, and stay informed about what industry events we’ll be attending this autumn. We hope you enjoy reading through these updates and look forward to keeping you informed throughout the year.
ANNOUNCEMENT: Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform
FACT SHEET: Certara.AI: The AI Platform Designed for Life Sciences
ANNOUNCEMENT: Certara Launches CoAuthor, a Regulatory and Medical Writing Tool
ARTICLE: Big Data Analytics - A Revolution in the Pharmaceutical Industry
Co-Authored by Christopher Bouton: Ph.D.: Head of AI, SVP at Certara
Recommended by LinkedIn
SOFTWARE: The Artificial Intelligence (AI) Platform Designed for Life Sciences
Reduce time, save money and improve your drug discovery process with the right data.
Register now to attend live scientific webinars
Where to find Certara this Fall
Enjoying the Inner Circle? Don't forget to subscribe at the top or bottom. Want to share? Click share below.
Have questions about our services and software? Contact us.
About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
Corporate Headquarters: 100 Overlook Center, Suite 101, Princeton, NJ 08540 USA